DEMENTIA, MILD
Clinical trials for DEMENTIA, MILD explained in plain language.
Never miss a new study
Get alerted when new DEMENTIA, MILD trials appear
Sign up with your email to follow new studies for DEMENTIA, MILD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could flickering lights and tones help fight Alzheimer's? major trial underway
Disease control OngoingThis study tests a device that delivers specific light and sound patterns to the brain, aiming to slow the progression of mild-to-moderate Alzheimer's disease. About 670 participants will use the device at home for an hour daily over a year, with half receiving a sham (inactive) …
Matched conditions: DEMENTIA, MILD
Phase: NA • Sponsor: Cognito Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New pill xanamem aims to slow Alzheimer's decline
Disease control OngoingThis study tests whether a daily 10 mg pill called Xanamem can safely slow memory and function loss in people with mild or moderate Alzheimer's dementia. About 247 participants will receive either Xanamem or a placebo for 36 weeks, with an option to continue the drug for up to 10…
Matched conditions: DEMENTIA, MILD
Phase: PHASE2, PHASE3 • Sponsor: Actinogen Medical • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
App could revolutionize dementia screening in primary care
Diagnosis OngoingThis study tests a new app called RACS that helps primary care doctors screen older adults for early cognitive decline. The app includes risk questions, a symbol matching task, and voice tasks. Researchers will enroll 500 adults aged 60 and older to see if the tool is easy to use…
Matched conditions: DEMENTIA, MILD
Phase: NA • Sponsor: University of Texas at Austin • Aim: Diagnosis
Last updated Jun 27, 2026 09:03 UTC
-
Could a video call replace the Doctor's office for dementia testing?
Diagnosis OngoingThis study is testing whether a set of memory and thinking tests, usually done in person, can be given remotely over a video call. Researchers will compare results from in-person and remote versions to see if they match. If it works, it could make dementia assessments easier for …
Matched conditions: DEMENTIA, MILD
Phase: NA • Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Diagnosis
Last updated Jun 26, 2026 19:03 UTC
-
Brain health study tests personalized coaching for memory decline prevention
Knowledge-focused OngoingThis study looks at whether giving older adults (ages 60-79) personalized advice and extra support helps them follow brain-healthy habits like a Mediterranean diet, exercise, and staying socially active. Participants have mild memory concerns or are at risk for cognitive decline.…
Matched conditions: DEMENTIA, MILD
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC
-
Brain scans track tau changes after Alzheimer's antibody treatment
Knowledge-focused ENROLLING_BY_INVITATIONThis study uses special brain scans (tau PET) to see how anti-amyloid immunotherapy affects tau protein buildup in people with mild Alzheimer's disease. About 135 participants will get two tau PET scans—one before starting treatment and another 12-18 months after finishing it. Th…
Matched conditions: DEMENTIA, MILD
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC